Phase IThyroid Analog
Compound 61674
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061674
Risk Class
MODERATE
Last Audit
Jun 6, 2108
Research Abstract
Thyroid Analog candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61674 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase i with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061674 with updates logged 2108-06-06.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61674Thyroid Analog Program 61674
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061674
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61674